Editorial commentary: High-sensitivity cardiac troponin: Like every new tool there is a learning curve

It is fascinating how a biomarker related to myocardial injury has garnered so much attention from both the clinical and clinical laboratory communities alike. Everett [1] provides a concise and thorough review on the utility and possible new roles for cardiac troponin testing, in particular on the emerging evidence of high-sensitivity cardiac troponin testing in the ambulatory population. As clearly articulated in the review article and perhaps not too surprising to those who have chronicled the evolution of cardiac troponin testing, “the therapeutic implications for individual patients remain decidedly murky” [1] when it comes to cardiac troponin testing in the non-acute care population.
Source: Trends in Cardiovascular Medicine - Category: Cardiology Authors: Source Type: research